glycyrrhizic acid has been researched along with Encephalopathy, Traumatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Angelopoulou, E; Othman, I; Paudel, YN; Piperi, C; Semple, B; Shaikh, MF | 1 |
| Chen, H; Chen, Z; Gao, T; Peng, X; Wang, Y; Wei, C; Xu, C; Yang, J; Yuan, H | 1 |
| Casillas-Espinosa, P; Crack, PJ; Dill, LK; Jones, NC; O'Brien, TJ; Ozturk, E; Semple, BD; Shultz, SR; Sun, M; Webster, KM | 1 |
3 other study(ies) available for glycyrrhizic acid and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders.
Topics: Animals; Anti-Inflammatory Agents; Brain; Brain Injuries, Traumatic; Female; Glycyrrhizic Acid; HMGB1 Protein; Male; Nervous System Diseases; Neuroprotective Agents; Rats, Wistar; Receptor for Advanced Glycation End Products; Signal Transduction | 2020 |
Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization.
Topics: Animals; Brain Injuries, Traumatic; Glycyrrhizic Acid; HMGB1 Protein; Macrophages; Male; Microglia; Neuroprotection; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2018 |
Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries, Traumatic; Glycyrrhizic Acid; HMGB1 Protein; Male; Mice; Mice, Inbred C57BL; Seizures | 2019 |